MarketPeel
Insider Trading Intelligence
OL

Oncology Impact Private Investment Fund 2, L.p.

AKTS
10% OWNER · AKTIS ONCOLOGY, INC. · CIK 0002104306
FILING MIX · LIFETIME57%/43%
BUYS
4
SELLS
3
TOTAL VALUE
$20.03M
COMPANIES
1
ACTIVE SINCE
Jan 2026
HOLDINGS NOW
0
AVG SELL PX
TRADE KIND
SHOWING 7 / 7
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Oncology Impact Private Investment Fund 2, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-13.70%-2.53%-11.17%-11.17%
14d1+0.00%-0.60%-0.35%-0.25%-0.25%
30d1+0.00%-16.97%-0.46%-16.50%-16.50%
60d1+0.00%-12.69%-4.73%-7.96%-7.96%
90d1+0.00%-20.28%-1.30%-18.97%-18.97%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AKTS · 0 shares · as of Jan 12, 2026
02,565,0165,130,0327,695,04810,260,064SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
FLOW · 4 buys / 3 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
1,314,2621,655,971Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
5,000,0000Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
6,000,0000Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
5,914,1977,570,168Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
1,112,777$18.00$20.03M10,260,064Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
1,577,1199,147,287Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
22,500,0000Jan 12, 2026Jan 14, 2026View →
Other insiders · AKTS
Loading peer insiders…
About this filer
CIK 0002104306
ROLE
10% Owner
PRIMARY
AKTS
COMPANIES
1
ACTIVE SINCE
Jan 2026
MARKETPEEL · /INSIDER/0002104306DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback